Texas Capital Bancshares’s Novo Nordisk NVO Stock Holding History

Texas Capital Bancshares’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$82K	Sell	1,477 -2,618	-64%	-$153K	0.03%	97
2025 Q2	$283K	Hold	4,095	–	–	0.1%	66
2025 Q1	$284K	Buy	4,095 +885	+28%	+$73.1K	0.12%	64
2024 Q4	$276K	Buy	3,210 +366	+13%	+$39.6K	0.11%	64
2024 Q3	$339K	Buy	2,844 +86	+3%	+$11.5K	0.14%	57
2024 Q2	$394K	Sell	2,758 -13	-0.5%	-$1.72K	0.16%	54
2024 Q1	$356K	Sell	2,771 -1,096	-28%	-$130K	0.16%	61
2023 Q4	$400K	Sell	3,867 -206	-5%	-$20.4K	0.21%	52
2023 Q3	$370K	Sell	4,073 -45	-1%	-$3.96K	0.2%	61
2023 Q2	$333K	Sell	4,118 -58	-1%	-$4.74K	0.19%	65
2023 Q1	$332K	Sell	4,176 -1,184	-22%	-$84K	0.21%	64
2022 Q4	$363K	Sell	5,360 -14	-0.3%	-$821	0.25%	61
2022 Q3	$268K	Hold	5,374	–	–	0.22%	63
2022 Q2	$299K	Sell	5,374 -538	-9%	-$29.9K	0.23%	63
2022 Q1	$328K	Sell	5,912 -24	-0.4%	-$1.23K	0.2%	65
2021 Q4	$332K	Buy	5,936 +218	+4%	+$11.8K	0.2%	66
2021 Q3	$274K	Sell	5,718 -62	-1%	-$3K	0.19%	66
2021 Q2	$242K	Buy	+5,780	New	+$224K	0.18%	68
2021 Q1	–	Sell	-5,812	Closed	-$203K	–	73
2020 Q4	$203K	Sell	5,812 -3,684	-39%	-$127K	0.27%	48
2020 Q3	$330K	Sell	9,496 -128	-1%	-$4.27K	0.46%	30
2020 Q2	$315K	Hold	9,624	–	–	0.47%	28
2020 Q1	$290K	Hold	9,624	–	–	0.51%	25
2019 Q4	$279K	Sell	9,624 -210	-2%	-$5.82K	0.39%	42
2019 Q3	$254K	Sell	9,834 -7,000	-42%	-$177K	0.41%	42
2019 Q2	$430K	Buy	16,834 +3,464	+26%	+$85.6K	0.72%	22
2019 Q1	$350K	Sell	13,370 -134	-1%	-$3.29K	0.64%	36
2018 Q4	$311K	Buy	13,504 +1,460	+12%	+$32.4K	0.71%	33
2018 Q3	$284K	Hold	12,044	–	–	0.6%	39
2018 Q2	$278K	Sell	12,044 -88	-0.7%	-$2.09K	0.6%	41
2018 Q1	$299K	Sell	12,132 -728	-6%	-$19.1K	0.7%	35
2017 Q4	$345K	Sell	12,860 -90	-0.7%	-$2.29K	0.77%	26
2017 Q3	$312K	Sell	12,950 -4,652	-26%	-$105K	0.7%	34
2017 Q2	$377K	Buy	+17,602	New	+$355K	0.85%	27
2015 Q2	–	Sell	-13,466	Closed	-$359K	–	131
2015 Q1	$359K	Buy	13,466 +162	+1%	+$3.73K	0.2%	78
2014 Q4	$282K	Sell	13,304 -560	-4%	-$12.5K	0.15%	108
2014 Q3	$330K	Sell	13,864 -44	-0.3%	-$1.01K	0.19%	78
2014 Q2	$321K	Sell	13,908 -350	-2%	-$7.73K	0.2%	84
2014 Q1	$325K	Buy	+14,258	New	+$304K	0.21%	94

Other funds holding NVO

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Texas Capital Bancshares's NVO Position: Q3 2025 in Review

Texas Capital Bancshares reduced its Novo Nordisk (NVO) stake by 64% in Q3 2025, selling an estimated $153K and leaving 1,477 shares worth $82K. The position accounts for 0.03% of the portfolio, ranked #97.

Texas Capital Bancshares first reported a position in NVO in Q1 2014 and has held it in 38 quarters since. The position peaked at $430K in Q2 2019. 1,396 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

Texas Capital Bancshares held 1,477 shares of Novo Nordisk worth $82K as of Q3 2025.
Texas Capital Bancshares sold 2,618 Novo Nordisk shares in Q3 2025, an estimated $153K.
Novo Nordisk made up 0.03% of Texas Capital Bancshares's portfolio in Q3 2025, its #97 holding.
Texas Capital Bancshares first reported a position in Novo Nordisk in Q1 2014 and has held it in 38 quarters since.
Texas Capital Bancshares's Novo Nordisk position peaked at $430K in Q2 2019.
1,396 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Texas Capital Bancshares's 13F filing for Q3 2025, filed 13 Nov 2025.